Efficacy and Safety of Botulinum Toxin A Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Review

被引：0
|
作者：
Irina Soljanik
机构：
[1] Heidelberg University Hospital,Neuro
来源：
Drugs | 2013年 / 73卷
关键词：
Spinal Cord Injury; Detrusor Overactivity; Spinal Cord Injury Patient; Intermittent Catheterization; Botulinum Neurotoxin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1055 / 1066
页数：11
相关论文
共 50 条
  • [31] Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder
    Kaga, Kanya
    Yamanishi, Tomonori
    Kaga, Mayuko
    Fuse, Miki
    Kamasako, Tomohiko
    Ishizuka, Mitsuru
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 899 - 904
  • [32] Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore
    Tow, Adela M.
    Toh, Khai-Lee
    Chan, Siew-Pang
    Consigliere, David
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (01) : 11 - 17
  • [33] Efficacy of overactive neurogenic bladder treatment : A systematic review of randomized controlled trials
    Bapir, Rawa
    Bhatti, Kamran Hassan
    Eliwa, Ahmed
    Garcia-Perdomo, Herney Andres
    Gherabi, Nazim
    Hennessey, Derek
    Magri, Vittorio
    Mourmouris, Panagiotis
    Ouattara, Adama
    Perletti, Gianpaolo
    Philipraj, Joseph
    Stamatiou, Konstantinos
    Trinchieri, Alberto
    Buchholz, Noor
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2022, 94 (04) : 492 - 506
  • [34] Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
    Le Maux, Amelie Huynh
    Pignol, Bernadette
    Behr-Roussel, Delphine
    Blachon, Jean-Luc
    Chabrier, Pierre-Etienne
    Compagnie, Sandrine
    Picaut, Philippe
    Bernabe, Jacques
    Giuliano, Francois
    Denys, Pierre
    TOXINS, 2015, 7 (12): : 5462 - 5471
  • [35] Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity
    Kalsi, Vinay
    Apostolidis, Apostolos
    Gonzales, Gwen
    Elneil, Sohier
    Dasyupta, Prokar
    Fowler, Clare J.
    EUROPEAN UROLOGY, 2008, 54 (01) : 181 - 187
  • [36] Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment
    S. H. Alloussi
    Ch. Lang
    R. Eichel
    A. Al-Kaabneh
    J. Seibold
    C. Schwentner
    S. Alloussi
    World Journal of Urology, 2012, 30 : 367 - 373
  • [37] Efficacy of onabotulinum toxin A injection in pediatric patients with non-neurogenic detrusor overactivity
    Bayrak, Omer
    Sadioglu, Erkan
    Sen, Haluk
    Dogan, Kazim
    Erturhan, Sakip
    Seckiner, Ilker
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (08) : 2078 - 2082
  • [38] Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment
    Alloussi, S. H.
    Lang, Ch.
    Eichel, R.
    Al-Kaabneh, A.
    Seibold, J.
    Schwentner, C.
    Alloussi, S.
    WORLD JOURNAL OF UROLOGY, 2012, 30 (03) : 367 - 373
  • [39] Botulinum toxin A for the treatment of neurogenic bladder in children: a systematic review and meta-analysis
    He, Guorong
    Shen, Nan
    Feng, Shaoguang
    ANZ JOURNAL OF SURGERY, 2024,
  • [40] Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity
    Kanagarajah, Prashanth
    Ayyathurai, Rajinikanth
    Caruso, Daniel J.
    Gomez, Christopher
    Gousse, Angelo E.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (01) : 91 - 97
12345